BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25632071)

  • 21. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.
    ; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Karafoulidou A; Miro JM; Lundgren J; Chene G; Egger M
    Antivir Ther; 2009; 14(8):1065-74. PubMed ID: 20032536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant lymphoma in the HIV-positive patient.
    Meister A; Hentrich M; Wyen C; Hübel K
    Eur J Haematol; 2018 Jul; 101(1):119-126. PubMed ID: 29663523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-Hodgkin's lymphoma as a rare manifestation of immune reconstitution disease in HIV-1 positive patients.
    Knysz B; Kuliszkiewicz-Janus M; Jeleń M; Podlasin R; Gładysz A
    Postepy Hig Med Dosw (Online); 2006; 60():547-51. PubMed ID: 17060896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era.
    Silverton A; Gunthel C; Adamski M; Mosunjac M; Nguyen ML
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):665-9. PubMed ID: 24707838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
    Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
    Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic variables and 4-year survival outcomes in CD20 Positive AIDS-Related Lymphoma in the Anti-retroviral treatment era: A Retrospective Review from a Single Centre in KwaZulu-Natal, South Africa.
    Rapiti N; Abdelatif N; Moosa MS
    PLoS One; 2022; 17(9):e0272282. PubMed ID: 36048870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma.
    Tam HK; Zhang ZF; Jacobson LP; Margolick JB; Chmiel JS; Rinaldo C; Detels R
    Int J Cancer; 2002 Apr; 98(6):916-22. PubMed ID: 11948473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-associated non-Hodgkin's lymphoma: experience from a regional cancer center.
    Sharma A; Bajpai J; Raina V; Mohanti BK
    Indian J Cancer; 2010; 47(1):35-9. PubMed ID: 20071788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.
    Vaccher E; Spina M; Talamini R; Zanetti M; di Gennaro G; Nasti G; Tavio M; Bernardi D; Simonelli C; Tirelli U
    Clin Infect Dis; 2003 Dec; 37(11):1556-64. PubMed ID: 14614680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical features and prognosis of 100 AIDS-related lymphoma cases.
    Wu D; Chen C; Zhang M; Li Z; Wang S; Shi J; Zhang Y; Yao D; Hu S
    Sci Rep; 2019 Mar; 9(1):5381. PubMed ID: 30926889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival among patients with primary central nervous system lymphoma, 1973-2004.
    Norden AD; Drappatz J; Wen PY; Claus EB
    J Neurooncol; 2011 Feb; 101(3):487-93. PubMed ID: 20556477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Hodgkin's lymphoma among patients infected with human immunodeficiency virus: the experience of a single center in Brazil.
    Tanaka PY; Pracchia LF; Calore EE
    Int J Hematol; 2006 Nov; 84(4):337-42. PubMed ID: 17118760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study.
    Lee SJ; Suh CW; Lee SI; Kim WS; Lee WS; Kim HJ; Choi CW; Kim JS; Shin HJ;
    Korean J Intern Med; 2014 May; 29(3):352-60. PubMed ID: 24851070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].
    Oriol A; Ribera JM; Flores A; Batlle M; las Heras G; Vaquero M; Juncá J; Millá F; Feliu E
    Med Clin (Barc); 1995 Mar; 104(8):281-6. PubMed ID: 7700086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility and Efficacy of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for HIV-Associated Lymphoma: A Single-Institution Experience.
    Ayala E; Chavez JC; Gomez A; Sleiman E; Kumar A; Kharfan-Dabaja MA
    Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):548-551. PubMed ID: 29937399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
    Achenbach CJ; Cole SR; Kitahata MM; Casper C; Willig JH; Mugavero MJ; Saag MS
    AIDS; 2011 Mar; 25(5):691-700. PubMed ID: 21160411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.
    Besson C; Lancar R; Prevot S; Algarte-Genin M; Delobel P; Bonnet F; Meyohas MC; Partisani M; Oberic L; Gabarre J; Goujard C; Boue F; Coppo P; Costello R; Hendel-Chavez H; Mekerri N; Dos Santos G; Recher C; Delarue R; Casasnovas RO; Taoufik Y; Mounier N; Costagliola D;
    AIDS; 2017 Nov; 31(18):2493-2501. PubMed ID: 28926410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort.
    Schommers P; Hentrich M; Hoffmann C; Gillor D; Zoufaly A; Jensen B; Bogner JR; Thoden J; Wasmuth JC; Wolf T; Oette M; Müller M; Esser S; Vehreschild JJ; Fätkenheuer G; Wyen C
    Br J Haematol; 2015 Mar; 168(6):806-10. PubMed ID: 25403997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
    Jaffe HW; De Stavola BL; Carpenter LM; Porter K; Cox DR;
    AIDS; 2011 Jul; 25(11):1395-403. PubMed ID: 21572307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.